⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Shenzhen Salubris Pharmaceuticals Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Shenzhen Salubris Pharmaceuticals Co., Ltd.
↗Shenzhen, China
Shenzhen Salubris Pharmaceuticals is a leading, innovation-driven Chinese pharmaceutical company founded in 1998. It specializes in the research, development, manufacturing, and marketing of products primarily focused on cardiovascular and cerebrovascular diseases, diabetes, oncology, and orthopedics.
The company operates a vertically integrated business model encompassing high-end chemical drugs, biological medicines, and medical devices. With a strong commitment to R&D, Salubris maintains multiple research centers across China and in the United States (Maryland) to connect global innovative resources and address significant unmet clinical needs.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Cardiovascular-Renal-Metabolic (CKM) therapeutics
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$550M-$750M
Founded:1998
Ownership:public
Status:operating
STOCK
Exchange:Shenzhen Stock Exchange
Ticker:002294.SZ
Market Cap:$4.4B - $7.7B
PIPELINE
Stage:Clinical
Lead Drug Stage:Phase 3
Modalities:Small molecule, Biologicals, Medical devices
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Salubris Biotherapeutics (SalubrisBio), Salubris Medical Technology
Key Partnerships:BioDuro-Sundia (Drug discovery)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Ye Yuxiang - Legal Representative/Director
Jie Yan - General Manager
LINKS
Website:salubris.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Shenzhen Salubris Pharmaceuticals Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.